Research and Vaccination - Clinical Research Informer

Trial success for 2 coronavirus vaccines backs up early research bets

Bio Pharma Dive

NOVEMBER 17, 2020

Positive results from Pfizer and Moderna offer the strongest validation yet of researchers' approach to coronavirus vaccines, but critical questions remain.

Vaccination

Vaccination Vaccine Research Trials

Cancer Research UK and CRIS fund lung cancer vaccine research

Pharmaceutical Technology

MARCH 25, 2024

Cancer Research UK and the CRIS Cancer Foundation have awarded a £1.7m ($2.1m) grant for developing the lung cancer vaccine LungVax.

Vaccination

Vaccination Vaccine Research Development

Researchers lay out hypothesis for rare side effect linked to AstraZeneca vaccine

Bio Pharma Dive

APRIL 9, 2021

The EMA has reiterated the benefits of the shot outweigh the risks, but the safety concerns are another hurdle to the vaccine's rollout in Europe.

Vaccination

Vaccination Vaccine Research

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

Nobel Prize awarded for research that paved the way for Covid-19 mRNA vaccines

Pharmaceutical Technology

OCTOBER 2, 2023

The Physiology and Medicine Prize has gone to two researchers whose work laid the foundation for Pfizer and Moderna’s Covid-19 vaccines.

Vaccination

Vaccination Vaccine Research Medicine

How did pharma develop a vaccine so quickly?

World of DTC Marketing

DECEMBER 29, 2020

OBSERVATION: Biologics can take a long time to develop but COVID vaccines have been in development for almost 50 years and novel approaches were used to develop these vaccines. Vaccines typically take 10 to 15 years to develop, test and release to the public. The coronavirus vaccines, however, took less than a year.

Vaccination

Vaccination Vaccine Development Clinical Trials

US FDA makes EUA changes to Pfizer-BioNTech and Moderna Covid-19 vaccines

Pharmaceutical Technology

APRIL 19, 2023

The US Food and Drug Administration (FDA) has made changes to the emergency use authorisations (EUAs) of the Pfizer -BioNTech and Moderna bivalent mRNA Covid-19 vaccines. The latest amendment aims to simplify the vaccination schedule for most people. The changes mean that the current bivalent vaccines for the original and Omicron BA.4/BA.5

Vaccination

Vaccination Vaccine Gene Therapy Gene

Optimism on Pfizer COVID vaccine is unwarranted

World of DTC Marketing

NOVEMBER 10, 2020

You need to ask yourself why in the hell Pfizer’s CEO would say that their vaccine is 90% effective when there is a lot more testing and review of data needed. However, there’s still a long way to go before researchers can be certain that this vaccine is indeed as effective as promised. The media has not been helpful.

Vaccination

Vaccination Vaccine Marketing Drugs

Russia, with scant study data, approves coronavirus vaccine

Bio Pharma Dive

AUGUST 11, 2020

The shot, developed by the state-backed Gamaleya Research Institute, hasn't yet been tested in the large, placebo-controlled tests scientists emphasize are needed to prove a vaccine is protective.

Vaccination

Vaccination Vaccine Scientist Development

PrEP therapies utter new hope in HIV preventive landscape as vaccine failures amass

Pharmaceutical Technology

DECEMBER 1, 2024

The HIV vaccine space has seen dwindling research activity as drug manufacturers turn to PrEP therapies for preventive treatment.

Vaccination

Vaccination Vaccine Manufacturing Drugs

Valneva’s Lyme disease vaccine faces final clinical test in a sparse landscape

Pharmaceutical Technology

AUGUST 17, 2022

On August 8, Pfizer and Valneva announced the initiation of a Phase III study with their Lyme disease vaccine , bringing the prospect of an injection to prevent the condition disease one step closer to reality. This means that the vaccine works against multiple serotypes of the disease, she explains. A one-size-fits-all approach.

Vaccination

Vaccination Vaccine Bacteria Protein

2023 in review: Cancer vaccines dose up on advances with tailored approaches

Pharmaceutical Technology

DECEMBER 22, 2023

As the number of patients with cancers continues to grow globally, research into personalised cancer vaccines is vital.

Vaccination

Vaccination Vaccine Research

Magazine-How delays derailed Covid-19 vaccination in Africa

Pharmaceutical Technology

JULY 1, 2022

Some months after the first Covid-19 vaccines became available, the World Health Organization (WHO) set a target of vaccinating 70% of each country’s population by the end of June 2022. The post Magazine-How delays derailed Covid-19 vaccination in Africa appeared first on Pharmaceutical Technology.

Vaccination

Vaccination Vaccine Big Data Development

Gilead adds investigational HIV vaccine to its portfolio from Spanish biotech

Pharmaceutical Technology

NOVEMBER 26, 2024

Gilead and Aelix first teamed up in 2018 for a clinical research collaboration agreement to investigate the vaccine.

Vaccination

Vaccination Vaccine Clinical Research Research

Oxford researchers launch HIV vaccine trial

Pharma Times

JULY 6, 2021

Vaccine will be evaluated in 13 HIV-negative adults aged 18-65 years old

Vaccination

Vaccination Vaccine Research Trials

Merck and Moderna partner to develop and sell cancer vaccine

Pharmaceutical Technology

OCTOBER 14, 2022

German pharmaceutical firm Merck has extended its partnership with Moderna to jointly develop and sell mRNA-4157/V940, an investigational personalised cancer vaccine (PCV). They subsequently expanded the collaboration to include the development of antigen mRNA cancer vaccines in 2018.

Vaccination

Vaccination Vaccine Development Immune Response

Consumers fall into three COVID-19 vaccine adoption segments

World of DTC Marketing

DECEMBER 11, 2020

(Mckinsey) Much of the prevailing market research on COVID-19 vaccination frames sentiment as “likely,” “unlikely,” or “neutral.” Their research has found that consumers’ attitudes towards receiving a COVID-19 vaccine fall into three primary segments.

Vaccination

Vaccination Vaccine Clinical Trials Clinical Trials

The TB Vaccine Mysteriously Protects Against Lots of Things. Now We Know Why

AuroBlog - Aurous Healthcare Clinical Trials blog

AUGUST 9, 2022

When babies in the African countries of Guinea Bissau and Uganda were given the tuberculosis vaccine, something remarkable happened. Skip advert Australian researchers […].

Vaccination

Vaccination Vaccine Bacteria Research

GreenLight and US NIH partner to develop Covid-19 vaccine for variants

Pharmaceutical Technology

AUGUST 1, 2022

GreenLight Biosciences has entered a partnership with the US National Institutes of Health (NIH) for the development of Covid-19 vaccines, which offer broader protection against new variants and with durable effects. They intend to develop vaccines that provide lasting immune responses compared to existing vaccines.

Vaccination

Vaccination Vaccine Development RNA

XtalPi and CK Life Sciences to develop AI-driven tumour vaccine R&D platform

Pharmaceutical Technology

NOVEMBER 25, 2022

XtalPi has entered a strategic partnership with CK Life Sciences for artificial intelligence (AI)-driven tumour vaccine research and development (R&D). Under the collaboration, the companies will utilise their capabilities to co-develop a new AI tumour vaccine R&D platform.

Life Science

Life Science Vaccination Vaccine Development

BARDA awards contract for Sabin’s Ebola Sudan and Marburg virus vaccines

Pharmaceutical Technology

JANUARY 13, 2023

The Biomedical Advanced Research and Development Authority (BARDA) has awarded a multi-year contract to the Sabin Vaccine Institute for developing and producing single-dose vaccine candidates for Ebola Sudan and Marburg virus diseases. Currently, there are no licensed vaccines against these viruses.

Vaccination

Vaccination Vaccine Clinical Trials Clinical Trials

Pfizer isn’t sharing Covid vaccines with researchers for next-gen studies

STAT News

SEPTEMBER 6, 2022

WASHINGTON — Researchers studying next-generation vaccines to fight an evolving Covid-19 threat are running into problems getting existing vaccines to use in their research. Right now, Pfizer isn’t sharing its vaccines for research purposes, a spokesperson confirmed to STAT.

Vaccination

Vaccination Vaccine Research Production

RVAC and University of Pennsylvania to develop mRNA vaccines

Pharmaceutical Technology

MARCH 20, 2023

RVAC Medicines has announced a research collaboration with the University of Pennsylvania (Penn) for the discovery and development of mRNA vaccines. The mRNA vaccine candidates will help reduce the chances of autoimmune responses that might lead to allergic conditions or serious autoimmune diseases.

Vaccination

Vaccination Vaccine Development Allergies

Top biopharmaceutical Covid-19 vaccine companies boosted with over 80% revenue growth

Pharmaceutical Technology

SEPTEMBER 15, 2022

Last year was a positive year for biopharmaceutical companies, particularly those with Covid-19 vaccines. As a result of huge global sales of mRNA Covid-19 vaccines, the split in profits between Pfizer and BioNTech’s Comirnaty contributed towards revenues of $81.3bn and $22.4bn last year, respectively. YoY revenue growth.

Vaccination

Vaccination Vaccine Sales Generic Drugs

Researchers publish first data on coronavirus vaccine approved by Russia

Bio Pharma Dive

SEPTEMBER 4, 2020

companies, the Russian vaccine could be used broadly because it doesn't need to be kept frozen. While the shot appeared less potent than those being advanced by U.S.

Vaccination

Vaccination Vaccine Research

Oragenics secures CQDM funding for Covid-19 vaccine antigen development

Pharmaceutical Technology

JUNE 6, 2023

Oragenics has secured funding from the Canadian bioresearch consortium CQDM to develop a variant-agnostic protein antigen for use in its Covid-19 intranasal vaccine. The project is a partnership with Inspirevax and the National Research Council of Canada (NRC).

Vaccination

Vaccination Vaccine Development Manufacturing

Race for universal flu vaccine ramps up as Osivax kicks off Phase IIa trial

Pharmaceutical Technology

JUNE 16, 2023

France-based biotech company Osivax has thrown its hat into the influenza ring by dosing the first subject with its vaccine candidate OVX836. The Phase IIa trial (NCT05734040) in Australia will see a potential 500 volunteers given OVX836 in combination with quadrivalent influenza vaccines (QIVs).

Vaccination

Vaccination Vaccine Trials Immune Response

Experimental Alzheimer’s Vaccine Shown to Delay Symptoms in Mice

AuroBlog - Aurous Healthcare Clinical Trials blog

AUGUST 3, 2023

An experimental vaccine that aims to slow down or prevent the progression of Alzheimer’s disease has been trialed in mice with promising early results. Mice engineered with genes that put them at greater risk of an Alzheimer’s-like disease had fewer amyloid plaques following the vaccine.

Vaccination

Vaccination Vaccine Engineer Gene

Malaria Could Be Eliminated by 2040: New Vaccine Offers Hope

AuroBlog - Aurous Healthcare Clinical Trials blog

OCTOBER 8, 2023

The World Health Organization has approved a new vaccine that scientists argue will be a game-changer in the fight against malaria, which kills half a million people in Africa every year.

Vaccination

Vaccination Vaccine Scientist Trials

ICMR and Panacea Biotec initiate phase 3 clinical trial for the first indigenous dengue vaccine, DengiAll

AuroBlog - Aurous Healthcare Clinical Trials blog

AUGUST 19, 2024

The Indian Council of Medical Research (ICMR) and Panacea Biotec have announced the initiation of the first-ever phase 3 clinical trial for a dengue vaccine in India. The trial will evaluate the efficacy of India’s indigenous tetravalent dengue vaccine, DengiAll, developed by Panacea Biotec.

Clinical Trials

Clinical Trials Clinical Trials Vaccination Vaccine

Signal: Project NextGen continues with $500m funding for vaccine research

Pharmaceutical Technology

OCTOBER 16, 2023

The US government's Covid-19 research programme has announced the vaccine candidates for its latest round of funding.

Vaccination

Vaccination Vaccine Research

India’s CDSCO approves Bharat Biotech’s intra-nasal vaccine for Covid-19

Pharmaceutical Technology

DECEMBER 2, 2022

India’s Central Drugs Standard Control Organisation (CDSCO) has granted approval for Bharat Biotech’s BBV154 vaccine for treating Covid-19. BBV154 is claimed to be the first intra-nasal vaccine for Covid-19 in the world.

Vaccination

Vaccination Vaccine Clinical Trials Clinical Trials

BioNTech Founders Predict Cancer Vaccine Is Only Years Away

AuroBlog - Aurous Healthcare Clinical Trials blog

OCTOBER 16, 2022

The husband-and-wife team who co-founded BioNTech, the biotechnology company that partnered with Pfizer to develop an effective messenger-RNA (mRNA) shot against COVID-19, has predicted that a cancer vaccine could be widely available within the next decade.

Vaccination

Vaccination Vaccine RNA Development

Extreme Case of Man Who Had 217 COVID Vaccines Surprises Scientists

AuroBlog - Aurous Healthcare Clinical Trials blog

MARCH 12, 2024

That’s how many vaccines a man in Germany claims to have received for COVID-19 in just 29 months – and his body isn’t reacting the way some scientists thought it would. Two hundred and seventeen. The 62-year-old male from the city of Magdeburg made headlines a few years ago for his private and risky decision […]

Scientist

Scientist Vaccination Vaccine Clinical Trials

India’s success story in pediatric vaccination program should be further replicated in adult vaccination: Experts

AuroBlog - Aurous Healthcare Clinical Trials blog

AUGUST 28, 2023

India’s success story in pediatric vaccination programme should be further replicated in the form of adult vaccination programme, experts recommended on the occasion of the 2nd edition of the India Vaccine Leaders Conclave (IVLC) held between August 22 and August 23, 2023 under the theme “Building Resilient Vaccine Ecosystems” in Mumbai.

Vaccination

Vaccination Vaccine Clinical Trials Clinical Trials

IISc develops heat-tolerant vaccine for protection against different strains of SARS-CoV-2 & future variants

AuroBlog - Aurous Healthcare Clinical Trials blog

JANUARY 22, 2024

The Indian Institute of Science (IISc) is now developing a heat-tolerant vaccine that can offer protection against different strains of SARS-CoV-2 – both current and future variants. The research […]

Vaccination

Vaccination Vaccine Development Research

Covid-19 vaccine success bolsters nanoparticle drug delivery research

Pharmaceutical Technology

APRIL 24, 2023

Robert Langer was part of the first cohort of researchers to begin nanoparticle research , as his lab at Cornell University developed tiny particles to deliver large molecules for angiogenesis. Langer, now a David H. Langer explains that nanoparticles can vary massively in formulation based on their uses.

Drug Delivery

Drug Delivery Vaccination Vaccine Research

SK bioscience and Doherty Institute partner on flu vaccine research

Pharmaceutical Technology

JUNE 28, 2023

SK bioscience and the Peter Doherty Institute have signed a research collaboration deal for the development of a influenza vaccine.

Vaccination

Vaccination Vaccine Research Development

SEC recommends permission to SII for Omicron XBB 1.5 variant Covid-19 vaccine

AuroBlog - Aurous Healthcare Clinical Trials blog

MAY 14, 2024

A Subject Expert Committee (SEC), which advices the national drug regulator on approvals and clinical trials related to Covid-19 vaccines, has recommended grant of permission to Serum Institute of India (SII) for Omicron XBB 1.5 The vaccine variant […]

Vaccination

Vaccination Vaccine Clinical Trials Clinical Trials

PETA India urges CPCSEA to withdraw recommendation for using stray dogs for vaccine testing

AuroBlog - Aurous Healthcare Clinical Trials blog

OCTOBER 17, 2022

Animal rights organisation People for Ethical Treatment of Animals (PETA) India has urged the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA) to withdraw its recent recommendations for using stray dogs for vaccine testing in favour of superior, human-relevant, animal-free research methods, which are more effective (..)

Vaccination

Vaccination Vaccine Research Clinical Trials

Brazil grants authorisation for Sinovac’s Covid-19 vaccine in children

Pharmaceutical Technology

JULY 15, 2022

The Brazilian Health Regulatory Agency (Anvisa) has granted emergency use authorization for Sinovac Biotech’s Covid-19 vaccine, CoronaVac, in children aged three to five years. Subjects in this age group can receive the same vaccine dosage authorised in patients aged six to 17 years, as well as adults.

Vaccination

Vaccination Vaccine Research

US researchers start trials of universal flu vaccine

pharmaphorum

SEPTEMBER 18, 2023

US researchers start trials of universal flu vaccine Phil.Taylor Mon, 18/09/2023 - 09:20 Bookmark this

Vaccination

Vaccination Vaccine Trials Research

UK firm starts research on skin patch for COVID vaccines

Pharma Times

JULY 31, 2020

The patch will be tested to deliver a vaccine dose via the skin, as well as achieve a simple and secure disposal process to enable at-home use.

Vaccination

Vaccination Vaccine Research

SEC recommends approval for Zydus Lifesciences’ trivalent influenza vaccine in children

AuroBlog - Aurous Healthcare Clinical Trials blog

MAY 13, 2024

The Subject Expert Committee (SEC), which advises the Central drug regulator regarding clinical trials and approvals of drugs, has recommended approval for additional indication of Zydus Lifesciences’ inactivated trivalent influenza vaccine in children above six months with clinical trial waiver subject to condition.

Vaccination

Vaccination Vaccine Clinical Trials Clinical Trials

Moderna’s HIV vaccine prepped for trials in Africa

pharmaphorum

MAY 19, 2022

Moderna has joined forces with non-profit organisation IAVI on a third phase 1 trial of its candidate HIV vaccine in Africa, where the burden of the virus is still being keenly felt. There are hopes that its mRNA approach, which proved so effective against COVID-19, could succeed where traditional vaccine technologies have failed in HIV.

Vaccination

Vaccination Vaccine Trials Immune Response

Trial success for 2 coronavirus vaccines backs up early research bets

Cancer Research UK and CRIS fund lung cancer vaccine research

Webinars

Trending Sources

Researchers lay out hypothesis for rare side effect linked to AstraZeneca vaccine

Webinars

Nobel Prize awarded for research that paved the way for Covid-19 mRNA vaccines

How did pharma develop a vaccine so quickly?

US FDA makes EUA changes to Pfizer-BioNTech and Moderna Covid-19 vaccines

Optimism on Pfizer COVID vaccine is unwarranted

Russia, with scant study data, approves coronavirus vaccine

PrEP therapies utter new hope in HIV preventive landscape as vaccine failures amass

Valneva’s Lyme disease vaccine faces final clinical test in a sparse landscape

2023 in review: Cancer vaccines dose up on advances with tailored approaches

Magazine-How delays derailed Covid-19 vaccination in Africa

Gilead adds investigational HIV vaccine to its portfolio from Spanish biotech

Oxford researchers launch HIV vaccine trial

Merck and Moderna partner to develop and sell cancer vaccine

Consumers fall into three COVID-19 vaccine adoption segments

The TB Vaccine Mysteriously Protects Against Lots of Things. Now We Know Why

GreenLight and US NIH partner to develop Covid-19 vaccine for variants

XtalPi and CK Life Sciences to develop AI-driven tumour vaccine R&D platform

BARDA awards contract for Sabin’s Ebola Sudan and Marburg virus vaccines

Pfizer isn’t sharing Covid vaccines with researchers for next-gen studies

RVAC and University of Pennsylvania to develop mRNA vaccines

Top biopharmaceutical Covid-19 vaccine companies boosted with over 80% revenue growth

Researchers publish first data on coronavirus vaccine approved by Russia

Oragenics secures CQDM funding for Covid-19 vaccine antigen development

Race for universal flu vaccine ramps up as Osivax kicks off Phase IIa trial

Experimental Alzheimer’s Vaccine Shown to Delay Symptoms in Mice

Malaria Could Be Eliminated by 2040: New Vaccine Offers Hope

ICMR and Panacea Biotec initiate phase 3 clinical trial for the first indigenous dengue vaccine, DengiAll

Signal: Project NextGen continues with $500m funding for vaccine research

India’s CDSCO approves Bharat Biotech’s intra-nasal vaccine for Covid-19

BioNTech Founders Predict Cancer Vaccine Is Only Years Away

Extreme Case of Man Who Had 217 COVID Vaccines Surprises Scientists

India’s success story in pediatric vaccination program should be further replicated in adult vaccination: Experts

IISc develops heat-tolerant vaccine for protection against different strains of SARS-CoV-2 & future variants

Covid-19 vaccine success bolsters nanoparticle drug delivery research

SK bioscience and Doherty Institute partner on flu vaccine research

SEC recommends permission to SII for Omicron XBB 1.5 variant Covid-19 vaccine

PETA India urges CPCSEA to withdraw recommendation for using stray dogs for vaccine testing

Brazil grants authorisation for Sinovac’s Covid-19 vaccine in children

US researchers start trials of universal flu vaccine

UK firm starts research on skin patch for COVID vaccines

SEC recommends approval for Zydus Lifesciences’ trivalent influenza vaccine in children

Moderna’s HIV vaccine prepped for trials in Africa

Stay Connected